Jens Kleesiek, Prof. Dr. med. Dr. rer. nat.

Jens Kleesiek is the chair for Translational Image-guided Oncology and heading the department Medical Machine Learning at the Institute for Artificial Intelligence in Medicine (IKIM) of the University Medicine Essen (UME). Focus of his research is on the application of self-supervised and weakly supervised learning paradigms for recognition of clinically relevant patterns in large and complex data, and the integration of multimodal data sources to enhance the decision-making process at the point of care. He studied medicine in Heidelberg and bioinformatics in Hamburg, where he obtained his PhD in computer science in 2012. After training at the University Hospital Heidelberg and the German Cancer Research Center (DKFZ), he obtained his board certification (Facharzt) in radiology, his habilitation (venia legendi) and specialization (Zusatzweiterbildung) in medical informatics.

Prof. Dr. Dr. Jens Kleesiek

Roland Schwarz, Prof. Dr. rer. nat.

Roland Schwarz joined the CCCE in January 2022 as the Chair for Computational Cancer Biology at the University Hospital Cologne. His group develops machine learning algorithms for understanding intra-tumour heterogeneity and inferring cancer evolution, focusing on chromosomal instability and genome structure. Roland studied computer science at the University of Würzburg and finished his PhD in 2009. He then became a postdoc at the Cancer Research UK Cambridge Institute and the University of Cambridge, and a Marie-Curie Fellow at EMBL’s European Bioinformatics Institute (EMBL-EBI). He also was awarded a Junior Research Fellowship at Wolfson College, University of Cambridge in 2010 and won the Prize of the Berlin-Brandenburg Academy of Sciences in Cancer Research in 2016. Later that year he moved to Berlin as a Junior Group Leader at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC).

Roland Schwarz

Christin Seifert, Prof. Dr. techn.

Christin Seifert has been appointed Chair of Medical Data Science in Oncology at the University of Duisburg-Essen in November 2020. She heads the department of Multimodal Computing & Machine Intelligence at the Institute for Artificial Intelligence in Medicine (IKIM) of the University Medicine Essen (UME). Her core research interests are machine learning with particular focus on explainable machine learning. Her research is characterised by interdisciplinarity and a broad range of application areas. Christin holds a Ph.D. from the Technical University Graz, Austria (Thesis Topic: Visually Supported Supervised Machine Learning) and a diploma (equiv. M.Sc.) in computer science from the Technical University Chemnitz, Germany. Before joining the CCCE she held assistant professorships at the University of Passau and the University of Twente, Enschede, the Netherlands and a visiting professorship at the Technical University of Dresden.

Christin Seifert

Renata Stripecke, Prof. Dr. rer. nat.

Renata Stripecke is a CCCE guest-professor and will join the University Hospital Cologne as a full professor (W3) and Chair for Translational Immuno-Oncology in July 2022. She is currently an Associate Professor (W2) in the Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation at the Hannover Medical School. Renata’s focus is the use of gene and immunotherapies for the treatment and eradication of cancer. Novel engineered dendritic and T cells are on the clinical development pipeline. Fully humanized mouse models boost her basic and translational research towards advanced immune-oncology concepts for patients. Renata is a molecular biologist with specialization in immunology and oncology. She obtained her PhD at EMBL in Heidelberg, and later her habilitation at the UKE in Hamburg. She performed her post-doctoral training in immunotherapy at the University of Southern California and was an assistant professor at the University of California, Los Angeles. She received the Research Special Fellow Award of The Leukemia and Lymphoma Society and the Howard Temin Award of the US-National Cancer Institute.

Renata Stripecke